Telomerase Activation in Hematological Malignancies
Cutaneous Lymphoma Oncogenesis Team INSERM U1053 Bordeaux Research in Translational Oncology, Bordeaux University, Bordeaux 33076, France
Institute of Biomedical Sciences of Abel Salazar, University of Porto, Porto 4050-313, Portugal
Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto 4200-135, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup)—Cancer Biology, Rua Dr. Roberto Frias, s/n, Porto 4200-465, Portugal
Tumor Bank and Tumor Biology Laboratory, University Hospital Center Bordeaux, Pessac 33604, France
Department of Pathology and Oncology, Medical Faculty of Porto University, Porto 4200-319, Portugal
Author to whom correspondence should be addressed.
Academic Editor: Gabriele Saretzki
Received: 1 June 2016 / Revised: 15 July 2016 / Accepted: 29 July 2016 / Published: 7 September 2016
Telomerase expression and telomere maintenance are critical for cell proliferation and survival, and they play important roles in development and cancer, including hematological malignancies. Transcriptional regulation of the rate-limiting subunit of human telomerase reverse transcriptase gen (hTERT)
is a complex process, and unveiling the mechanisms behind its reactivation is an important step for the development of diagnostic and therapeutic applications. Here, we review the main mechanisms of telomerase activation and the associated hematologic malignancies.
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Scifeed alert for new publications
Never miss any articles
matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
Define your Scifeed now
Share & Cite This Article
MDPI and ACS Style
Ropio, J.; Merlio, J.-P.; Soares, P.; Chevret, E. Telomerase Activation in Hematological Malignancies. Genes 2016, 7, 61.
Ropio J, Merlio J-P, Soares P, Chevret E. Telomerase Activation in Hematological Malignancies. Genes. 2016; 7(9):61.
Ropio, Joana; Merlio, Jean-Philippe; Soares, Paula; Chevret, Edith. 2016. "Telomerase Activation in Hematological Malignancies." Genes 7, no. 9: 61.
Show more citation formats
Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.